Dietary vitamin K (phylloquinone) consumption has been documented to have an inhibitory effect on systemic inflammation by reducing the level of pro-inflammatory cytokines, particularly tumor necrosis factor-α and interleukin-6, a well-known factor for promoting the onset and development of cancer [134]. This evidence concerns the gene IL6 and cancer.